YOUR BUSINESS AUTHORITY
Springfield, MO
Gilead Sciences has agreed to buy cancer therapy company Arcellx.
The deal is valued at up to $7.8 billion.
The companies entered a cell therapy development collaboration in 2022.
Read more from Reuters.
Complete with a 45-foot pedestrian bridge, this project adds a 10-foot-wide walking trail in front of Nixa’s High Pointe Elementary School and Summit Intermediate School.